Femoral nerve block with ropivacaine or bupivacaine in day case anterior crucial ligament reconstruction
Authors:
- 25 February 2010
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 54 (4) , 414-420
Abstract
Background/Objective: Our aim was to evaluate analgesia, motor block and pharmacokinetics of ropivacaine 0.2% and 0.75% in a femoral nerve block (FNB) in day case patients for anterior crucial ligament (ACL)‐reconstruction compared with bupivacaine 0.25% and placebo.Methods: Following ethics committee approval and informed consent, 280 patients were randomly allocated to four groups for single‐shot FNB [30 ml ropivacaine 0.2% (group RO2.0), 0.75% (RO7.5), bupivacaine 0.25% (BU2.5) and NaCl 0.9% (NaCl)]. Analgesia (pain scores, primary outcome) and motor block were assessed at 4 h (dismissal) and up to 24 h. Plasma concentration was determined up to 240 min thereafter.Results: Pain scores at 4 h were significantly higher for NaCl 4 (0–8) (median, range) (vs.) BU2.5 2 (0–8), RO2.0 3 (0–9) and RO7.5 2 (0–8) (NS within the LA groups). Patients of the NaCl group needed analgesics significantly more often (93%) within 4 h after surgery vs. 16% of group RO2.0, 19% of group RO7.5 and 19% of group BU2.5. Motor block was significantly increased with all local anesthetics without a significant difference within the LA groups 3 (0–5) in RO2.0, 3 (0–5) in RO7.5 and 3 (0–4) in BU2.5 vs. 0 (0–3) in group NaCl (median (range); scale from 0=full strength to 5=complete paralysis). Peak plasma concentrations differed significantly: RO7.5: 1.4 ± 0.4 (0.73–2.6) [μg/ml, mean ± SD (range)] after 33 ± 14 (10–40) min, RO2.0: 0.6 ± 0.3 (0.13–1.0) after 22+17 (10–60) and BU2.5: 0.3 ± 0.16 (0.05–0.62) at 31 ± 17 (10–60), respectively.Conclusion: FNB for ACL reconstruction with ropivacaine or bupivacaine provided better post‐operative analgesia than placebo without reaching toxic plasma concentrations. Significant motor block was observed after 4 h in all groups including the lowest concentration of ropivacaine but occurred even with placebo.Keywords
This publication has 22 references indexed in Scilit:
- A Comparison of the Pharmacodynamics and Pharmacokinetics of Bupivacaine, Ropivacaine (with Epinephrine) and Their Equal Volume Mixtures with Lidocaine Used for Femoral and Sciatic Nerve Blocks: A Double-Blind Randomized StudyAnesthesia & Analgesia, 2009
- Single-injection femoral nerve block with 0.25% ropivacaine or 0.25% bupivacaine for postoperative analgesia after total knee replacement or anterior cruciate ligament reconstructionJournal of Clinical Anesthesia, 2008
- The pharmacokinetics of ropivacaine after four different techniques of brachial plexus blockadeAnaesthesia, 2007
- RopivacaineDrugs, 2005
- Plasmakonzentrationen von Ropivacain und Bupivacain während postoperativer Patienten-kontrollierter thorakaler EpiduralanalgesieAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 2003
- Clinical Usefulness, Safety, and Plasma Concentration of Ropivacaine 0.5% for Inguinal Hernia Repair in Regional AnesthesiaRegional Anesthesia & Pain Medicine, 2001
- Pharmacokinetics and Pharmacodynamics of Ropivacaine 2 mg/mL, 5 mg/mL, or 7.5 mg/mL After Ilioinguinal Blockade for Inguinal Hernia Repair in AdultsAnesthesia & Analgesia, 1999
- Pharmacodynamics and Pharmacokinetics of Epidural Ropivacaine in HumansAnesthesia & Analgesia, 1990
- Cardiotoxicity of ropivacaine – a new amide local anaesthetic agentActa Anaesthesiologica Scandinavica, 1989
- THE EFFECT OF LOCAL ANAESTHETICS ON THE CENTRAL CIRCULATION AND RESPIRATION IN MAN AND DOG1),2)Acta Anaesthesiologica Scandinavica, 1968